Refine by
Clinical Pharmaceutical Articles & Analysis
103 news found
Boston: “According to the latest BCC Research study, the demand for Medical Kiosks: Global Market and Forecasts is estimated to increase from $1.4 billion in 2022 to reach $3.2 billion by 2028, at a compound annual growth rate (CAGR) of 14.8% from 2022 through 2028.” The comprehensive report on the medical kiosks market delivers a thorough analysis of its current landscape and future ...
The company offers a variety of products and services for businesses of all sizes, including data analysis, modeling, and strategy consulting, with a broad client base in industries such as pharmaceutical and clinical, finance, and ...
Efficient leadership plays a huge role in bringing a clinical trial to fruition. Pharmaceutical companies are not immune to making mistakes and facing failures. ...
By eliminating the need for additional immunohistochemistry, 4D Path’s cloud-based platform accelerates complete, actionable and objective insight leading to expedited and democratized precision medicine for optimized patient care and clinical trials. 4D Path’s cloud-based, quantitative approach provides clinical solutions in both companion ...
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today provided a business update and guidance for 2023. ...
Cellworks Group Inc., a leader in Personalized Therapy Biosimulation, today announced the launch of its Precision Drug Development business units aimed at accelerating time-to-market for drug development and reviving previously studied but unapproved pharmaceutical assets through predictive biosimulation. The two new business units will use Cellworks’ biosimulation platform ...
LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. ...
To view LIXTE Biotechnology Holdings' presentation at the Planet MicroCap conference, register in advance at: https://planetmicrocapshowcase.com/signup The Planet MicroCap Showcase: VIRTUAL 2022 website is available at https://planetmicrocapshowcase.com/ All company presentations as part of the conference will be available directly on the conference event platform on this link under the tab ...
Drug formulation, or pharmaceutical formulation, is a universal challenge faced by biotech companies developing new drugs that enter clinical trials. ...
Today, DNAnexus has more than 12,000 users across 48 countries and works with the largest and most innovative pharmaceutical companies, diagnostic laboratories, and academic medical centers around the world, along with the UK Biobank and the FDA. ...
Iterative Health, formerly known as Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, has announced a rebrand to reflect the company’s success in utilizing artificial intelligence (AI) to strengthen clinical research and augment clinical decision making within gastroenterology. ...
IO-108 is being studied as a monotherapy and in combination with select anti-PD-1 antibodies in multiple expansion cohorts of solid tumors Clinical supply agreement with Regeneron accelerates Immune-Onc’s solid tumor clinical development program Immune-Onc Therapeutics, Inc. ...
This clearance further validates the quality and clinical efficacy of the company’s artificial intelligence (AI)-powered precision imaging and analytics solutions. ...
(Nasdaq: LIXT), (“LIXTE” or the “Company”), a clinical-stage pharmaceutical company focused on developing and commercializing cancer therapies, announced that the Spanish Agency for Medicines and Health Products (Agencia Española de Medicamentos y Productos Sanitarios, AEMPS) has authorized a Phase 1b/randomized Phase 2 study of ...
Pravibismane has also demonstrated safety in multiple clinical studies including treatment of patients with diabetic foot infections and patients with serious orthopedic device-related infections. Several positive signals of efficacy (not statistically significant) were appreciated in these early clinical studies. About Microbion Microbion is a ...
“This new patent with granted pharmaceutical composition claims is a key patent in our growing patent ...
AT-Patch is distributed to domestic clinics through Hanmi Pharmaceutical Co., Ltd. Expect to expand ATsens' product line with this Strategic MOU ...
SAN DIEGO–(BUSINESS WIRE)–Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight, announces the acceptance and presentation of a poster highlighting its latest clinical results at the upcoming Global Specialty Lens Symposium (GSLS), a leading eye ...
Investor participation was spurred by the continued momentum of SEngine’s platform in both drug discovery and clinical diagnostics. The inclusion of Vincere in this closing represents the beginning of significant partnership, making the PARIS® Test more broadly available through its network of cancer centers. ...
Raimar Loebenberg as the 2022 recipient of the CSPS Award of Leadership in Canadian Pharmaceutical Sciences. Dr. Loebenberg is a Professor in the Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta (“UoA”), the founder and director of the Drug Development and Innovation Centre (DDIC), UoA, and is a director and founder of XPhyto ...